Weekly update from Chancellor Jones (March 5)
We are sharing exciting news about our saliva-based COVID-19 test.
The University of Illinois System received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the innovative saliva-based COVID-19 test.
We are updating our university community on COVID-19 variant B.1.1.7.
The university has been working closely with the Champaign-Urbana Public Health District (CUPHD) to monitor local cases of a new COVID-19 variant known as B.1.1.7.
We are reminding students, faculty and staff to maintain their regular testing schedule and follow COVID-19 safety protocols.
Continue to check the testing locations page or your Safer Illinois app before testing at your usual location. Students who are out of compliance may also lose access to university Wi-Fi, Zoom, Compass and other technologies.
We are continuing to share updated vaccine information.
Champaign-Urbana Public Health District (CUPHD) is leading vaccination distribution in our county, and the university will share vaccine information with you as it becomes available.
I am grateful for your efforts as we work to maximize the safety of our university community. Please feel free to direct questions to covid-19@illinois.edu.
Sincerely,
Robert J. Jones